Items tagged with Advocacy

Securing our TB-free future: eastern European and central Asian health leaders increase political commitment to ending TB (post)

24 June 2024, Tashkent, Uzbekistan --The Stop TB Partnership and WHO Regional Office for Europe have brought together 100 key stakeholders and partners from 13 countries of eastern Europe and central Asia for the first time since the United Nations High-Level Meeting last September, to discuss and debate the status of the tuberculosis (TB) airborne pandemic, the high rates of drug-resistant TB (DR-TB) and challenges towards ending this disease.

OVERDUE: Including pregnant participants in TB research - webinar materials now available online (post)

The SMART4TB Consortium hosted a webinar on 20 June 2024 about the consensus process and statement for earlier inclusion of pregnant women and persons in TB research. It featured advocates sharing their experiences with TB and pregnancy, and profiling SMART4TB studies that are responding to the call for inclusion.

Critics blast ‘inward, technocratic’ MSF leadership for closing Access Campaign (post)

The leadership of Médecins sans Frontières (MSF) is under significant global pressure to reverse its decision to close its Access Campaign.

Updates on important WHO events (post)

The World Health Organization (WHO) provided updates on several important events hosted by the organization and its partners in June 2024 in Dhaka, Bangladesh: first Global Forum on Advancing Multisectoral and Multistakeholder Engagement and Accountability to End TB (23-24 June); #Youth2EndTB Townhall (23 June); annual meeting of the Stop TB Working Group on Public-Private Mix (PPM) for TB prevention and care (25-26 June); consultation on enhanced TB-PPM data dashboards with seven PPM priority countries (27 June). The WHO policy brief: "Public-Private Mix Data Dashboards for Enhanced Action and Accountability to End TB" was launched and disseminated at the consultation.

Johnson & Johnson's patent for paediatric TB drug rejected in India, move hailed as 'significant victory' for children (post)

New Delhi: In a big victory for TB activism and children suffering from TB in India, the country’s patent office rejected Johnson & Johnson’s (J&J) patent application for the paediatric formulation of Bedaquiline on Friday, July 5.

The Union Conference: Community Connect Engagement Activities - applications invited (post)

Community Connect, an open-access space, is a valuable addition and important highlight of The Union World Conference of Lung Health 2024.

Better, shorter TB treatments are available. Why aren’t more people receiving them? (post)

TB activists co-founded the 1/4/6×24 Campaign to demand the universal implementation of shorter and more effective TB regimens: as little as one month or once weekly for TB prevention, four months for drug-sensitive TB, and six months for drug-resistant TB by the end of 2024.

Community engagement webinar: 7th Global Forum on TB Vaccines (post)

You are invited to attend the first community engagement webinar for the 7th Global Forum on TB Vaccines (8-10 October 2024, Rio de Janeiro, Brazil).

Request for proposals: Fast Track the Cure: Community engagement and awareness building for new DR-TB treatments (post)

The TB Alliance Fast Track the Cure initiative launched a Request for proposals (RFP): Fast Track the Cure: Community engagement and awareness building for new drug-resistant TB (DR-TB) treatments.

(post with image)